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Abstract
Background—Since 2010, the Advisory Committee on Immunization Practices (ACIP) has 
recommended that all persons aged ≥6 months receive annual influenza vaccination.
Methods—We analyzed data from the 2015 National Internet Flu Survey (NIFS), to assess 
knowledge and awareness of the influenza vaccination recommendation and early influenza 
vaccination coverage during the 2015–16 season among adults. Predictive marginals from a 
multivariable logistic regression model were used to identify factors independently associated with 
adults’ knowledge and awareness of the vaccination recommendation and early vaccine uptake 
during the 2015–16 influenza season.
Results—Among the 3301 respondents aged ≥18 years, 19.6% indicated knowing that influenza 
vaccination is recommended for all persons aged ≥6 months. Of respondents, 62.3% indicated 
awareness that there was a recommendation for influenza vaccination, but did not indicate correct 
knowledge of the recommended age group. Overall, 39.9% of adults aged ≥18 years reported 
having an influenza vaccination. Age 65 years and older, being female, having a college or higher 
education, not being in work force, having annual household income ≥$75,000, reporting having 
received an influenza vaccination early in the 2015–16 season, having children aged ≤17 years in 
the household, and having high-risk conditions were independently associated with a higher 
correct knowledge of the influenza vaccination recommendation.
Conclusions—Approximately 1 in 5 had correct knowledge of the recommendation that all 
persons aged ≥6 months should receive an influenza vaccination annually, with some socio-
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economic groups being even less aware. Clinic based education in combination with strategies 
known to increase uptake of recommended vaccines, such as patient reminder/recall systems and 
other healthcare system-based interventions are needed to improve vaccination, which could also 
improve awareness.
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Influenza; Influenza vaccine; Vaccination; Coverage; Adult; Knowledge of influenza vaccination 
recommendation; National Internet Flu Survey (NIFS); The Advisory Committee on 
Immunization; Practices (ACIP)
1. Introduction
Influenza is a major cause of morbidity and mortality among adults in the United States [1–
4]. Influenza illness burden among healthy adults 18–49 years is an important cause of 
outpatient medical visits and loss of workdays [5,6]. Influenza vaccination has been shown 
to be a cost-effective tool for reducing morbidity and mortality associated with influenza 
among adults [5,7–18].
Prior to 2010, the adult groups recommended for annual vaccination included persons 50 
years and older, pregnant women, persons 18–49 years with medical conditions associated 
with higher risk of complications from influenza infection, healthcare personnel, and close 
contacts of high-risk persons [19]. Since the 2010–11 influenza season, the Advisory 
Committee on Immunization Practices (ACIP) has recommended annual influenza 
vaccination for all persons 6 months of age and older, including healthy adults 18–49 years 
who were not close contacts of persons at high-risk [1] Healthy adults aged 18–49 year was 
added to the recommendations in the 2010–11 season given the known significant morbidity 
and economic impact of influenza in working age adults [1]. In addition, the universal 
vaccination recommendation also eliminates the need to determine whether each person has 
one or more specific indications for vaccination and emphasizes the importance of 
preventing influenza among persons of all ages [1].
Influenza vaccination is the most effective strategy for preventing influenza and its 
complications; however, vaccination coverage has been suboptimal [1,20–22]. Knowledge 
and awareness of the influenza vaccination recommendation might be related to vaccination 
coverage [20,23], but information about levels of knowledge and association between 
knowledge and vaccination among adult population groups is limited.
Data from the 2015 National Internet Flu Survey (NIFS) were analyzed to assess knowledge 
and awareness of influenza vaccination recommendation and early vaccination during the 
2015–16 season among adults aged ≥18 years in the United States.
2. Methods
The NIFS is an annual survey and collects information about early-season influenza 
vaccination, and knowledge, attitudes, behaviors, and barriers related to influenza and 
influenza vaccination in the non-institutionalized U.S. adult population. The 2015 NIFS was 
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conducted for Centers for Diseases Control and Prevention (CDC) by RTI International and 
GfK Custom Research, LLC during October 29–November 11, 2015. The survey was 
conducted using a probability-based Internet panel, the GfK KnowledgePanel, designed to 
be representative of the non-institutionalized U.S. population 18 years or older® [24].
For this ongoing panel, participants are initially chosen by a random selection of telephone 
numbers and residential addresses. Persons in selected households are then invited by 
telephone or mail to participate in the web-enabled KnowledgePanel®. For those who agree 
to participate but do not already have Internet access, both a laptop and Internet access are 
provided at no cost. The laptop was delivered to the residence of the panel members in 
exchange for members completing a short survey on a weekly basis. The device is theirs to 
keep if they remain on the panel for three years. Most members are able to install the 
hardware without additional assistance, although GfK maintains a telephone technical 
support line and will, when needed, provide on-site installation. Panel members may contact 
the panel member support department for questions using a toll-free number. Totally, of the 
3301 members who completed the survey, 250 were furnished with devices/internet access 
by GfK. People who already have computers and Internet service participate using their own 
equipment.
The 2015 NIFS sampling design was a single-stage stratified sample with oversampling of 
select subgroups of particular analytical interest. Twelve mutually exclusive design strata 
were defined as the interaction of two categorical variables—age (18–49 years, 50–64 years, 
and 65 years and older) and race/ethnicity (Hispanic, non-Hispanic white, non-Hispanic 
black, and non-Hispanic other/multiple races)—known for all members of the probability-
based Internet panel. Independent random samples were selected within each design stratum. 
A total of 6148 panel members across the 12 design strata were randomly sampled using 
probabilities of selection inversely proportional to the KnowledgePanel® survey weight (a 
base weight adjusted for nonresponse) from 42,075 eligible panelists, with a target of 4025 
completed surveys. A total of 3301 completed the survey, with a completion rate of 53.7% 
(unweighted), and 57.6% (weighted).
In the 2015 NIFS, a new question was added to the survey regarding knowledge of the 
influenza vaccination recommendation that all persons age 6 months and older be 
vaccinated.
Respondents were asked: “Who do you believe the flu vaccine is recommended for?” The 
potential answers to the question included: (1) all persons age 13 years and older; (2) only 
adults age 18 years and older with chronic medical conditions; (3) all persons age 6 years 
and older; (4) all persons age 6 months and older; (5) persons of any age; (6) none of the 
above; (7) don’t know. Individuals could select only one response to this question. Persons 
who stated “(4) all persons age 6 months and older” were considered to have correct 
knowledge of the influenza vaccination recommendation. Respondents who answered either 
“(1) all persons age 13 years and older” or “(2) only adults age 18 years and older with 
chronic medical conditions” or “(3) all persons age 6 years and older” or “(5) persons of any 
age” were considered to have awareness that there was a recommendation for influenza 
vaccination, but not the correct knowledge of the recommended age group. Persons who 
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stated either “(6) none of the above” or “(7) don’t know” were considered to have neither 
knowledge nor awareness of the influenza vaccination recommendation.
To determine influenza vaccination coverage, respondents were asked: “Since July 1, 2015, 
have you had flu vaccination?” and individuals were considered to have received an 
influenza vaccination if they reported having received the vaccine since July 1, 2015. 
Influenza vaccination coverage estimates represent approximately the cumulative proportion 
of persons vaccinated by the time the survey was conducted [21]. Metropolitan Statistical 
Areas (MSA) status is categorized as metro and non-metro. Metro includes anyone in a 
metropolitan areas (having at least one urbanized area of 50,000 or more population plus 
adjacent territory that has a high degree of social and economic integration with the core as 
measured by commuting ties) or micropolitan areas (having at least one urban cluster of at 
least 10,000 but less than 50,000 population, plus adjacent territory that has a high degree of 
social and economic integration with the core as measured by commuting ties). Non-metro 
includes anyone living outside of both a metropolitan and micropolitan area.
SAS release 9.3 (SAS Inc. Cary, NC) and SUDAAN 11.0 (RTI, Research Triangle Park, NC) 
were used to calculate point estimates and 95% confidence intervals for knowledge or 
awareness of the influenza vaccination recommendation, and early season influenza 
vaccination coverage. T-tests were used to test for differences in knowledge or awareness of 
the influenza vaccination recommendation, neither knowledge nor awareness of influenza 
vaccination recommendation, and vaccination coverage and for each variable. A two-sided 
significance level of 0.05 was adopted for all statistical tests. All percentages in the tables 
were weighted estimates and the tests were conducted based on the weighted estimates. 
Multivariable logistic regression models with predictive marginals were used to identify 
factors independently associated with knowledge or awareness of the influenza vaccination 
recommendation, neither knowledge nor awareness of influenza vaccination 
recommendation, and influenza vaccination coverage among adult populations. We did t-
tests for each variable within each column, and the reference group for each variable within 
each column is shown in Table 4. Independent variables in the models which may be 
associated with vaccination or awareness of recommendation were selected based on 
previous studies [20,22–23].
3. Results
Sociodemographic and access-to-care characteristics of the study population are shown in 
Table 1.
Among all adults aged ≥18 years, only 19.6% indicated correct knowledge of the influenza 
vaccination recommendation (those who answered that “the vaccine is recommended for all 
persons age 6 months and older”) (Table 2). Among those indicating correct knowledge of 
the influenza vaccination recommendation, influenza vaccination coverage was 53.5%, 
significantly higher than those with incorrect answers including, “only adults age 18 years 
and older with chronic medical conditions” (33.4%); “all persons age 6 years and older” 
(40.1%); “persons of any age” (39.4%); “none of the above” (16.6%); and “don’t know” 
(23.3%) (Table 2).
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In bi-variable analyses (Table 3), 62.3% reported being aware that influenza vaccination is 
recommended, and 18.1% reported having neither knowledge nor awareness of 
recommendation. Knowledge of the correct influenza vaccination recommendation was 
significantly higher (26.8%) among those who received vaccination compared with those 
who had not (15.4%) (Table 3). Overall, 39.9% of adults aged ≥18 years reported having an 
influenza vaccination by the date they completed the NIFS interview. The following factors 
were significantly associated with a higher level of correct knowledge of the influenza 
vaccination recommendation: age ≥65 years, being female, having a college or higher 
education, not being in the workforce, household income ≥$50,000, reporting having 
received an influenza vaccination early in the 2015–16 season, having children aged ≤17 
years in the household, and having high-risk conditions (Table 3). Being in the 50–64 years 
age group, non-Hispanic black race/ethnicity, and never having been married were 
significantly associated with a lower level of correct knowledge of the influenza vaccination 
recommendation. Having children aged ≤17 years in the household was the common factor 
that was significantly associated with correct knowledge, awareness, and neither knowledge 
nor awareness of influenza vaccination recommendation. Other factors that were associated 
with knowledge or awareness, and neither knowledge nor awareness were shown in Table 3. 
The following factors were significantly associated with higher influenza vaccination 
coverage: age ≥50 years, having a college or higher education, not being in the workforce, 
indicating correct knowledge of influenza vaccination recommendation, reporting having 
visited a doctor or healthcare professional since July 1 and having received a 
recommendation with or without offer for vaccination, and having high-risk conditions. 
Being of non-Hispanic black race/ethnicity, never having been married, neither having 
correct knowledge nor awareness of influenza vaccination recommendation, and having 
children aged 6–17 years in the household were significantly associated with a lower 
coverage level of influenza vaccination (Table 3).
In multivariable analyses, among adults ≥18 years, the following factors were significantly 
associated with a higher level of correct knowledge of influenza vaccination 
recommendation: age ≥65 years, being female, having a college or higher education, not 
being in work force, having annual household income ≥$75,000, reporting having received 
an influenza vaccination early in the 2015–16 season, having children aged ≤17 years in the 
household, and having one or more high-risk conditions. Being of non-Hispanic black race/
ethnicity was significantly associated with a lower level of correct knowledge of influenza 
vaccination recommendation (Table 4). Having children aged ≤17 years in the household 
was the common factor that was significantly associated with correct knowledge, awareness, 
and neither knowledge nor awareness of influenza vaccination recommendation. Other 
factors that were associated with awareness and neither knowledge nor awareness were 
shown in Table 4. Among adults ≥18 years, the following factors were significantly 
associated with a higher level of influenza vaccination: age ≥50 years, having a college or 
higher education, indicating knowledge of influenza vaccination recommendation, reporting 
having visited a doctor or healthcare professional since July 1 and having received a 
recommendation with or without offer for vaccination, and having high-risk conditions 
(Table 4).
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4. Discussion
Less than 1 in 5 adults in the United States had correct knowledge of the ACIP 
recommendation that all persons aged ≥6 months should receive an influenza vaccination 
annually, with some socio-economic groups being even less knowledgeable. However, more 
than 3 in 5 adults in the United States were aware that there is a recommendation for 
influenza vaccination, although they did not know the correct recommended age group. Less 
than half of adults reported vaccination by early November 2015. Since 2010, annual 
influenza vaccination recommendation has been recommended for all persons 6 months of 
age and older [1]. To our knowledge, this is the first comprehensive assessment of 
knowledge of the influenza vaccination recommendation, providing data on associations 
with the sociodemographic characteristics. Such information can assist efforts to develop 
strategies to improve knowledge and vaccination coverage among adult populations.
Overall, based on our study, 39.9% of adults aged ≥18 years reported having an influenza 
vaccination by the date they completed their survey. Vaccination coverage increases by the 
end of season; however, increases are limited, since most people receive their vaccination 
before December with only about 8% of individuals being vaccinated from December 
through May [21]. Although influenza vaccination was recommended to all adults aged ≥18 
years since 2010–11 season, coverage was low by 2015 based on our study. Increased 
influenza vaccination coverage among adult populations is needed. Strategies to increase 
vaccination coverage include assessment of patients’ vaccination indications by healthcare 
providers and routine recommendation and offer of needed vaccines to adults, 
implementation of client reminder-recall systems, and use of provider reminders for 
vaccination [22,25–30].
This study showed that age ≥50 years, having a college or higher education, and having 
high-risk conditions were significantly associated with influenza vaccination, consistent with 
other studies [25,26]. Reporting having visited a doctor or healthcare professional and 
having received a recommendation with or without offer for vaccination were significantly 
associated with influenza vaccination, suggesting that receiving a recommendation for 
vaccination from a healthcare provider plays an important role in early season influenza 
vaccine uptake, and an offer can increase the likelihood of vaccination uptake. Provider 
reminders can help ensure a provider remembers to recommend vaccination. Additionally, 
knowledge of the influenza vaccination recommendation was significantly associated with 
influenza vaccination after controlling for other factors, highlighting the importance of 
knowledge in efforts to increase vaccination coverage.
Overall, only 19.6% indicated correct knowledge that influenza vaccination is recommended 
for all persons aged ≥6 months. This rate is low given that influenza is one of the most 
common infectious diseases that causes substantial morbidity and mortality among adults in 
the United States. Additionally, universal influenza vaccination recommendation was widely 
covered by media when CDC launched the new recommendation in 2010. Furthermore, 
CDC invests in a national awareness campaign annually to educate the general population 
about the importance of influenza vaccination through a mix of communication channels and 
in collaboration with national and grass-root partners (e.g., local faith-based or community-
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based organizations who coordinating immunization clinics) who organize influenza 
promotion activities and events [1,31,32]. Approximately 36.0% of adults answered that 
“persons of any age” are recommended to receive influenza vaccination, which indicated 
that some individuals might be confused with the correct recommendation of “all persons 
aged ≥6 months”. The lower knowledge of influenza vaccination recommendation observed 
in this study (19.6%) could be compared with findings from an influenza A (H1N1) 2009 
monovalent vaccine (pH1N1 vaccine) study, which also indicated low knowledge of 
influenza vaccination recommendations [23]. In that study, only 29.5% of recommended 
adults correctly reported being in the target groups recommended to receive the pH1N1 
vaccine, despite comprehensive media coverage in the wake of the influenza A (H1N1) 
pandemic and distribution of the pH1N1 vaccine [23]. Several characteristics were 
independently associated with correct knowledge or awareness of the influenza vaccination 
recommendation after controlling for other factors. Both female gender and higher education 
were associated with correct knowledge, which is consistent with previous studies [33–39]. 
This findings are important for identifying intervention programs to improve awareness 
among those groups. Efforts to better educate men and those with lower levels of education 
about influenza vaccination recommendation might improve vaccination.
Having children aged ≤17 years in the household was associated with knowledge of the 
correct influenza vaccination recommendation. Adults without children in the households 
might pay less attention to the details of influenza vaccination recommendations and focus 
on and remember what applies to themselves. Adults with children in the household have 
more contact with healthcare providers, and in general have more opportunities to discuss 
vaccination recommendations with providers, and provider recommendation has been 
previously shown to influence vaccine uptake [40–43], which might explain the observed 
association between having children in the household with correct knowledge of the 
influenza vaccination recommendation. In addition, adults with children, especially small 
children in the household are likely to have an increased uptake of influenza vaccination to 
protect their children.
Fewer Non-Hispanic black adults had correct knowledge of the influenza vaccination 
recommendation compared with non-Hispanic white adults. Similar significant racial/ethnic 
differences among adults in knowledge of other recommended vaccines such as herpes 
zoster vaccination [44] and human papillomavirus vaccination have been previously reported 
[36,39,45,46]. This finding might reflect lower prevalence of vaccination services being 
offered to black patients, and lower knowledge levels can limit the ability of patients to 
request vaccination when appropriate [36,39,45,46]. A lack of knowledge regarding 
recommended vaccinations could translate into a missed opportunity for protection against 
vaccine preventable diseases. Since patients may not seek vaccination services, each 
provider visit, including non-routine visits, is a critical opportunity to ensure provider 
implementation of vaccination services, assessing vaccination needs and recommending 
necessary adult vaccines to protect adult patients and improve coverage. Clinic based 
education in combination with strategies known to increase uptake of recommended 
vaccines, such as patient reminder/recall systems and other healthcare system-based 
interventions are needed to improve vaccination, which could also improve awareness.
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Having received an influenza vaccination early in the 2015–16 season was independently 
associated with correct knowledge of the influenza vaccination recommendation, indicating 
that vaccination coverage might be related to knowledge of the recommendation. 
Additionally, among those who answered “None of the above (listed answers)” or “Don’t 
know” had particularly lower influenza vaccination coverage (16.6%, and 23.3%, 
respectively), indicating that lack of knowledge and awareness of the recommendation is 
related to lower vaccination coverage. In addition, our study showed that more persons with 
high-risk conditions had correct knowledge of the influenza vaccination recommendation 
compared to persons without a high-risk condition. Persons with high-risk conditions have 
more frequent physician contact and more opportunities to discuss their health status and 
vaccination indications with their providers. Future interventions targeting healthcare 
providers could help increase influenza vaccine acceptability and uptake. For example, 
physician vaccination reminder systems may help increase vaccination coverage but are 
underused by healthcare providers [47,48].
The findings in this study are subject to two limitations. Data for this study were collected 
by self-report and vaccination was not verified by medical records and may be subject to 
recall bias [49]. Estimates based on self-report may over or underestimate vaccination 
coverage. However, self-reported influenza vaccination status among adults has been shown 
to be sensitive and specific with vaccination status ascertained from medical records [50]. 
Second, NIFS is an Internet panel survey and although the Internet panel was probability-
based, the estimates may not represent all adults in the United States (for example, the 
response rate is 57.6% and non-responders existed, and the institutionalized adult 
populations were excluded from the survey), and bias may remain after the weighting 
adjustments [51]. This limitation may over- or under-estimate vaccination coverage. Third, 
the representativeness of the respondents which appear to make up of a considerably high 
number of non-Hispanic white only, household income ≥$75,000, and living in the South, 
which may also have impact on our results. Finally, this findings is based on a single year 
survey only, monitoring the future knowledge and coverage levels are necessary.
Overall, less than half of adults reported vaccination by early November. Five years have 
passed since ACIP recommended annual influenza vaccination in the 2010–11 season to all 
persons aged ≥6 months, only less than 1 in 5 adults in the United States had knowledge of 
this influenza vaccination recommendation in 2015, with some socio-economic groups being 
even less knowledgeable. Increasing demand for vaccinations through client reminder and 
recall systems or clinic-based education with expanded access across all healthcare settings, 
including pharmacies, may help improve knowledge of influenza vaccination 
recommendation and increase vaccination coverage [28,52].
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Table 1
Demographic characteristics of adults aged 18 years and older, United States, National Internet Flu Survey 
2015.
Characteristic Sample
Size, Na
Weighted
Percentage, %
Total 3301 100.0
Age
  18–49 years 1508 54.7
  50–64 years 1033 26.0
  65 years and older 760 19.3
Gender
  Male 1622 48.3
  Female 1679 51.7
Race/ethnicity
  Non-Hispanic white only 1922 65.5
  Non-Hispanic black only 494 11.8
  Hispanic 460 14.1
  Non-Hispanic, other or multiple races 425 8.6
Marital status
  Married/living with partner 1950 57.9
  Widowed/divorced/separated 616 17.7
  Never married 735 24.5
Education level
  High school or less 1161 41.4
  Some college 956 28.5
  College degree or higher 1184 30.1
Employment
  Employed 1862 58.5
  Unemployed 188 6.3
  Not in work force 1251 35.2
Annual incomeb
  <$35,000 945 27.2
  $35,000–$49,999 374 11.6
  $50,000–$74,999 628 17.9
  $75,000+ 1354 43.3
Region of residence
  Northeast 590 18.1
  Midwest 693 21.4
  South 1185 37.1
  West 833 23.4
Received an influenza vaccination
  Yes 1354 39.9
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Characteristic Sample
Size, Na
Weighted
Percentage, %
  No 1894 60.1
Knowledge/awareness of recommendation for influenza vaccination
  Correct knowledgec of recommendation 645 19.6
  Awarenessd of recommendation 2048 62.3
  Neither knowledge nor awareness of recommendation 585 18.1
Visit to healthcare professional/received recommendation/offer for flu vaccination
  Doctor visit/received recommendation/offered flu vaccination 661 19.7
  Doctor visit/received recommendation/not offered flu vaccination 268 7.9
  Doctor visit/not received recommendation/not offered flu vaccination 845 28.5
  Did not visit doctor or healthcare professional 1229 43.9
Metropolitan statistical area status
  Metro 2885 85.0
  Non-metro 416 15.0
Children in household
  No Children 2432 71.2
  Children aged ≤5 years 175 5.6
  Children aged 6–17 years 694 23.2
High-risk condition statuse
  With high-risk conditions 1079 30.5
  Without high-risk conditions 2222 69.5
aUnweighted sample size.
bAnnual household income.
cAdults who answered “all persons age 6 months and older” to the survey question, “Who do you believe the flu vaccine is recommended for” were 
considered to have correct knowledge about the ACIP recommendation for influenza vaccination.
dAdults who answered either “all persons age 13 years and older” or “only adults age 18 and older with chronic medical conditions” or “all persons 
age 6 years and older” or “persons of any age” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered 
to have awareness that there was a recommendation for influenza vaccination, but did not indicate correct knowledge of the recommended age 
group.
eAdults were considered having a high-risk condition if they had ever been told by a doctor or other health professional that they had chronic 
asthma, a lung condition other than asthma, diabetes, heart disease (other than high blood pressure, heart murmur, or mitral valve prolapse), a 
kidney condition, a liver condition, obesity, sickle cell anemia or other anemia, a neurologic or neuromuscular condition that makes it difficult to 
cough, or a weakened immune system caused by chronic illness or by medicines taken for chronic illness such as cancer, chemotherapy, HIV/
AIDS, steroids, and transplant medicines.
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Table 3
Knowledge and awareness of influenza vaccination recommendation and vaccination coverage among adults 
≥18 years by demographic characteristics - United States, National Internet Flu Survey 2015.
Knowledgea of influenza
vaccination
recommendation
Awarenessb of influenza
vaccination
recommendation
Neither knowledge 
nor awareness of
influenza 
vaccination
recommendation
Early season 
influenza
vaccination 
coverage
Characteristic % (95% CIc) % (95% CI) % (95% CI) % (95% CI)
Overall 19.6 (18.1, 21.2) 62.3 (60.3, 64.2) 18.1 (16.6, 19.7) 39.9 (38.0, 41.8)
Age
  18–49 yearsd 19.4 (17.2, 21.9) 62.7 (59.7, 65.6) 17.9 (15.6, 20.4) 31.8 (29.1, 34.7)
  50–64 years 15.9 (13.5, 18.6) 64.6 (61.2, 67.8) 19.6 (17.0, 22.4) 41.3 (37.9, 44.7)
  65 years and older 25.2 (21.9, 28.7) 58.1 (54.1, 61.9) 16.8 (14.0, 20.0) 60.4 (56.4, 64.2)
Gender
  Maled 15.4 (13.5, 17.6) 62.6 (59.7, 65.4) 22.0 (19.6, 24.5) 37.9 (35.2, 40.7)
  Female 23.5 (21.2, 26.0) 62.0 (59.2, 64.7) 14.5 (12.6, 16.6) 41.7 (38.9, 44.5)
Race/ethnicity
  Non-Hispanic white onlyd 21.5 (19.5, 23.5) 60.1 (57.7, 62.5) 18.4 (16.5, 20.4) 41.6 (39.2, 44.0)
  Non-Hispanic black only 13.8 (10.6, 17.7) 67.3 (62.1, 72.1) 18.9 (15.1, 23.4) 35.5 (30.4, 40.9)
  Hispanic 17.8 (13.5, 23.2) 65.4 (59.3, 71.1) 16.8 (12.6, 22.0) 36.8 (31.0, 42.9)
  Non-Hispanic, other or multiple races 16.2 (11.9, 21.7) 66.9 (60.4, 72.9) 16.8 (12.4, 22.4) 37.9 (31.7, 44.6)
Marital status
  Married/living with partnerd 22.2 (20.1, 24.4) 61.1 (58.6, 63.7) 16.7 (14.8, 18.8) 42.6 (40.1, 45.1)
  Widowed/divorced/separated 21.3 (17.7, 25.4) 61.0 (56.4, 65.5) 17.7 (14.5, 21.4) 46.1 (41.5, 50.9)
  Never married 12.3 (9.7, 15.4) 66.0 (61.7, 70.1) 21.7 (18.2, 25.7) 28.6 (24.9, 32.7)
Education level
  High school or lessd 16.5 (14.1, 19.2) 63.5 (60.2, 66.8) 19.9 (17.3, 22.8) 37.7 (34.5, 41.0)
  Some college 18.7 (15.9, 21.8) 62.7 (59.0, 66.3) 18.6 (15.8, 21.8) 35.9 (32.4, 39.5)
  College degree or higher 24.7 (22.0, 27.6) 60.2 (56.9, 63.3) 15.1 (13.0, 17.6) 46.6 (43.4, 49.9)
Employment
  Employedd 18.7 (16.7, 20.9) 63.1 (60.4, 65.6) 18.3 (16.2, 20.5) 36.2 (33.7, 38.7)
  Unemployed 14.1 (8.6, 22.0) 71.6 (63.1, 78.8) 14.3 (9.7, 20.7) 28.7 (21.3, 37.5)
  Not in work force 22.1 (19.6, 24.9) 59.4 (56.1, 62.5) 18.5 (16.0, 21.2) 47.9 (44.6, 51.2)
Annual incomee
  <$35,000d 15.1 (12.6, 18.0) 60.9 (57.0, 64.8) 23.9 (20.6, 27.6) 36.8 (33.0, 40.7)
  $35,000–$49,999 19.5 (14.9, 25.0) 62.7 (56.6, 68.5) 17.8 (13.6, 22.9) 38.6 (32.8, 44.7)
  $50,000–$74,999 19.8 (16.4, 23.8) 64.7 (60.1, 69.1) 15.4 (12.3, 19.2) 42.3 (37.8, 46.9)
  $75,000+ 22.3 (19.9, 25.0) 62.0 (59.0, 64.9) 15.7 (13.6, 18.0) 41.2 (38.3, 44.1)
Region of residence
  Northeastd 18.4 (15.1, 22.3) 65.5 (60.9, 69.8) 16.1 (12.9, 19.9) 41.6 (37.0, 46.4)
  Midwest 20.0 (16.8, 23.7) 59.1 (54.8, 63.3) 20.9 (17.6, 24.6) 42.7 (38.5, 46.9)
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Knowledgea of influenza
vaccination
recommendation
Awarenessb of influenza
vaccination
recommendation
Neither knowledge 
nor awareness of
influenza 
vaccination
recommendation
Early season 
influenza
vaccination 
coverage
  South 20.8 (18.2, 23.6) 61.6 (58.3, 64.9) 17.6 (15.1, 20.5) 39.6 (36.3, 42.9)
  West 18.3 (15.4, 21.7) 63.8 (59.8, 67.7) 17.9 (15.0, 21.2) 36.5 (32.7, 40.5)
Received influenza vaccination
  Yes 26.8 (24.1, 29.6) 63.6 (60.6, 66.6) 9.6 (8.0, 11.6) NAf
  Nod 15.4 (13.6, 17.5) 61.7 (59.0, 64.3) 22.9 (20.7, 25.3) NA
Knowledge of recommendation for influenza vaccination
  Yes NA NA NA 53.5 (49.0, 58.0)
  Nod NA NA NA 36.5 (34.4, 38.6)
Awareness of recommendation for influenza vaccination
  Yes NA NA NA 40.6 (38.2, 43.1)
  Nod NA NA NA 38.6 (35.5, 41.8)
Neither knowledge nor awareness of recommendation for 
influenza vaccination
  Yes NA NA NA 21.8 (18.2, 25.9)
  Nod NA NA NA 43.7 (41.6, 45.9)
Visit to healthcare professional/received recommendation/offer for influenza vaccination
  Doctor visit/received 
recommendation/offered influenza 
vaccination
20.8 (17.3, 24.8) 66.2 (61.8, 70.4) 13.0 (10.3, 16.4) 64.7 (60.3, 69.0)
  Doctor visit/received 
recommendation/not offered influenza 
vaccination
21.3 (16.2, 27.3) 64.8 (58.0, 71.0) 14.0 (9.7, 19.6) 47.8 (41.1, 54.6)
  Doctor visit/not received 
recommendation/not offered influenza 
vaccination
20.5 (17.5, 23.9) 62.5 (58.7, 66.2) 17.0 (14.3, 20.1) 33.4 (29.9, 37.2)
  Did not visit doctor or healthcare 
professionald
19.1 (16.7, 21.8) 61.0 (57.7, 64.2) 19.9 (17.3, 22.7) 29.5 (26.6, 32.6)
Metropolitan statistical area status
  Metro 19.3 (17.7, 21.0) 62.8 (60.7, 64.9) 17.9 (16.2, 19.7) 40.0 (38.0, 42.2)
  Non-metrod 21.3 (17.0, 26.4) 59.4 (53.9, 64.7) 19.3 (15.4, 23.9) 39.0 (33.8, 44.4)
Children in household
  No Childrend 16.0 (14.4, 17.6) 64.1 (61.8, 66.3) 20.0 (18.1, 21.9) 42.5 (40.3, 44.8)
  Children aged ≤5 years 38.0 (29.9, 46.8) 50.0 (41.2, 58.8) 12.0 (7.3, 19.2) 43.5 (34.9, 52.6)
  Children aged 6–17 years 26.3 (22.5, 30.6) 59.8 (55.3, 64.1) 13.9 (11.1, 17.3) 30.8 (27.0, 35.0)
High-risk condition statusg
  With high-risk conditions 22.4 (19.5, 25.5) 64.5 (61.0, 67.8) 13.2 (11.1, 15.6) 49.1 (45.6, 52.6)
  Without high-risk conditionsd 18.4 (16.6, 20.3) 61.3 (58.9, 63.7) 20.3 (18.3, 22.4) 35.8 (33.5, 38.2)
Note: Boldface indicates significance (p < 0.05 comparing to the reference group).
aAdults who answered “all persons age 6 months and older” to the survey question, “Who do you believe the flu vaccine is recommended for” were 
considered to have correct knowledge about the ACIP recommendation for influenza vaccination.
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bAdults who answered either “all persons age 13 years and older” or “only adults age 18 and older with chronic medical conditions” or “all persons 
age 6 years and older” or “persons of any age” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered 
to have awareness that there was a recommendation for influenza vaccination, but did not indicate correct knowledge of the recommended age 
group.
cConfidence interval.
d
Reference level.
eAnnual household income.
fNot Applicable.
gAdults were considered having a high risk condition if they had ever been told by a doctor or other health professional that they had chronic 
asthma, a lung condition other than asthma, diabetes, heart disease (other than high blood pressure, heart murmur, or mitral valve prolapse), a 
kidney condition, a liver condition, obesity, sickle cell anemia or other anemia, a neurologic or neuromuscular condition that makes it difficult to 
cough, or a weakened immune system caused by chronic illness or by medicines taken for chronic illness such as cancer, chemotherapy, HIV/
AIDS, steroids, and transplant medicines.
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Table 4
Multivariable logistic regression analysis of factors associated with knowledge and awareness of the influenza 
vaccination recommendation and vaccination coverage among adults >18 years by demographic characteristics 
- United States, National Internet Flu Survey 2015.
Knowledgea of influenza
vaccination
recommendation
Awarenessb of influenza
vaccination
recommendation
Neither knowledge 
nor awareness of
influenza 
vaccination
recommendation
Early season 
influenza
vaccination 
coverage
Characteristic % (95% CIc) % (95% CI) % (95% CI) % (95% CI)
Age
  18–49 yearsd Reference Reference Reference Reference
  50–64 years 1.00 (0.79, 1.26) 1.00 (0.92, 1.09) 1.03 (0.82, 1.30) 1.17 (1.01, 1.35)
  65 years and older 1.47 (1.13, 1.91) 0.90 (0.80, 1.02) 0.95 (0.70, 1.31) 1.64 (1.40, 1.93)
Gender
  Maled Reference Reference Reference Reference
  Female 1.49 (1.25, 1.77) 0.99 (0.92, 1.05) 0.69 (0.57, 0.83) 1.05 (0.95, 1.16)
Race/ethnicity
  Non-Hispanic white onlyd Reference Reference Reference Reference
  Non-Hispanic black only 0.67 (0.49, 0.92) 1.15 (1.05, 1.26) 0.86 (0.65, 1.15) 0.88 (0.74, 1.03)
  Hispanic 0.91 (0.68, 1.21) 1.06 (0.95, 1.19) 0.94 (0.69, 1.29) 1.08 (0.92, 1.27)
  Non-Hispanic, other or multiple races 0.78 (0.56, 1.08) 1.13 (1.02, 1.26) 0.80 (0.57, 1.12) 1.02 (0.85, 1.23)
Marital status
  Married/living with partnerd Reference Reference Reference Reference
  Widowed/divorced/separated 1.15 (0.92, 1.44) 0.96 (0.87, 1.06) 1.02 (0.80, 1.30) 0.99 (0.86, 1.14)
  Never married 0.95 (0.73, 1.24) 1.02 (0.92, 1.12) 0.98 (0.74, 1.28) 0.88 (0.76, 1.03)
Education level
  High school or lessd Reference Reference Reference Reference
  Some college 1.10 (0.88, 1.37) 0.97 (0.89, 1.05) 1.02 (0.82, 1.28) 1.00 (0.88, 1.15)
  College degree or higher 1.37 (1.10, 1.70) 0.93 (0.85, 1.01) 0.90 (0.71, 1.14) 1.32 (1.16, 1.49)
Employment
  Employedd Reference Reference Reference Reference
  Unemployed 1.02 (0.65, 1.59) 1.10 (0.96, 1.26) 0.68 (0.43, 1.06) 0.96 (0.75, 1.24)
  Not in work force 1.04 (0.84, 1.29) 0.95 (0.87, 1.04) 1.11 (0.87, 1.41) 0.93 (0.82, 1.06)
Annual incomee
  <$35,000d Reference Reference Reference Reference
  $35,000–$49,999 1.36 (0.99, 1.86) 1.02 (0.90, 1.16) 0.71 (0.52, 0.98) 1.02 (0.85, 1.21)
  $50,000–$74,999 1.15 (0.86, 1.52) 1.10 (0.99, 1.22) 0.67 (0.50, 0.89) 1.13 (0.97, 1.31)
  $75,000+ 1.32 (1.00, 1.73) 1.05 (0.94, 1.16) 0.68 (0.53, 0.88) 1.03 (0.89, 1.18)
Region of residence
  Northeastd Reference Reference Reference Reference
  Midwest 0.97 (0.75, 1.26) 0.95 (0.85, 1.05) 1.29 (0.96, 1.73) 1.00 (0.86, 1.17)
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Knowledgea of influenza
vaccination
recommendation
Awarenessb of influenza
vaccination
recommendation
Neither knowledge 
nor awareness of
influenza 
vaccination
recommendation
Early season 
influenza
vaccination 
coverage
  South 1.08 (0.86, 1.36) 0.96 (0.87, 1.05) 1.08 (0.81, 1.43) 0.98 (0.85, 1.13)
  West 0.97 (0.75, 1.26) 0.97 (0.88, 1.07) 1.16 (0.86, 1.56) 0.91 (0.78, 1.06)
Received influenza vaccination
  Yes 1.55 (1.31, 1.84) 1.04 (0.97, 1.11) 0.47 (0.37, 0.59) NAf
  Nod Reference Reference Reference NA
Knowledge of recommendation for influenza vaccination
  Yes NA NA NA 1.33 (1.19, 1.48)
  Nod NA NA NA Reference
Visit to healthcare professional/received recommendation/offer for influenza vaccination
  Doctor visit/received 
recommendation/offered influenza 
vaccination
0.84 (0.67, 1.07) 1.10 (1.01, 1.20) 0.87 (0.66, 1.13) 1.91 (1.69, 2.17)
  Doctor visit/received 
recommendation/not offered influenza 
vaccination
1.01 (0.76, 1.33) 1.06 (0.94, 1.19) 0.82 (0.56, 1.20) 1.37 (1.15, 1.63)
  Doctor visit/not received 
recommendation/not offered influenza 
vaccination
0.94 (0.77, 1.15) 1.03 (0.95, 1.12) 0.97 (0.78, 1.20) 1.04 (0.90, 1.20)
  Did not visit doctor or healthcare 
professionald
Reference Reference Reference Reference
Metropolitan statistical area status
  Metro 0.83 (0.66, 1.06) 1.04 (0.94, 1.16) 1.07 (0.82, 1.40) 0.98 (0.85, 1.14)
  Non-metrod Reference Reference Reference Reference
Children in household
  No Childrend Reference Reference Reference Reference
  Children aged ≤5 years 2.63 (2.01, 3.43) 0.79 (0.65, 0.95) 0.46 (0.25, 0.82) 1.18 (0.95, 1.46)
  Children aged 6–17 years 1.92 (1.57, 2.36) 0.90 (0.82, 1.00) 0.66 (0.50, 0.88) 0.87 (0.75, 1.01)
High-risk condition statusg
  With high-risk conditions 1.20 (1.01, 1.43) 1.02 (0.95, 1.10) 0.76 (0.60, 0.95) 1.15 (1.04, 1.28)
  Without high-risk conditionsd Reference Reference Reference Reference
Note: Boldface indicates significance (p < 0.05 comparing to the reference group).
aAdults who answered “all persons age 6 months and older” to the survey question, “Who do you believe the flu vaccine is recommended for” were 
considered to have correct knowledge about the ACIP recommendation for influenza vaccination.
bAdults who answered either “all persons age 13 years and older” or “only adults age 18 and older with chronic medical conditions” or “all persons 
age 6 years and older” or “persons of any age” to the survey question, “Who do you believe the flu vaccine is recommended for” were considered 
to have awareness that there was a recommendation for influenza vaccination, but did not indicate correct knowledge of the recommended age 
group.
cConfidence interval.
d
Reference level.
eAnnual household income.
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fNot Applicable
gAdults were considered having a high risk condition if they had ever been told by a doctor or other health professional that they had chronic 
asthma, a lung condition other than asthma, diabetes, heart disease (other than high blood pressure, heart murmur, or mitral valve prolapse), a 
kidney condition, a liver condition, obesity, sickle cell anemia or other anemia, a neurologic or neuromuscular condition that makes it difficult to 
cough, or a weakened immune system caused by chronic illness or by medicines taken for chronic illness such as cancer, chemotherapy, HIV/
AIDS, steroids, and transplant medicines.
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